Obesity Medicine
Издатель: Elsevier · ISSN 2451-8476 · 24 статей
-
Obesity-driven gut-immune-brain axis dysregulation: Emerging molecular targets and biomaterial-based interventions
Publication date: September 2026 Source: Obesity Medicine, Volume 63 Author(s): Nazmul MHM, Vetriselvan Subramaniyan, Srikumar Chakravarthi, Thidar Aung, Sergey Gupalo, Wana Hla Shwe, Sutha Devaraj, Phone Myint Htoo, Myat Myo Naing, Lei...
-
Methionine methylsulfonium chloride prevents obesity-induced vascular injury in Wistar rats via antioxidant, anti-inflammatory, and anti-apoptotic mechanisms
Publication date: September 2026 Source: Obesity Medicine, Volume 63 Author(s): Peace Omamurhomu Oyibocha, Jerome Ndudi Asiwe, Ogheneochuko Ewhrudje, Julian Enwerim Nwangwa, Eze Kingsley Nwangwa
-
Exercise induced irisin dynamics and their correlation with beta cell function and peripheral insulin sensitivity in diabetes
Publication date: September 2026 Source: Obesity Medicine, Volume 63 Author(s): Harshalata Sahare, Amol Tatode, Mohammad Qutub, Milind Umekar, Brijesh Taksande, Tanvi Premchandani, Sakshi Nalkande
-
Sociodemographic correlates of body mass index among obese adults in urban Lahore: A cross-sectional study
Publication date: September 2026 Source: Obesity Medicine, Volume 63 Author(s): Anam Farzand, Mohd Adzim Khalili Rohin, Abdul Momin Rizwan Ahmad, Sana Javaid Awan, Hafiz Ayaz Ahmad, Hiba Akram
-
Multifactorial dysregulation of the insulin signalling pathway in Gestational Diabetes Mellitus: a systematic review of mechanisms and therapeutic targets over the past decade
Publication date: September 2026 Source: Obesity Medicine, Volume 63 Author(s): Deeksha Chahar, Gyanendra Kumar Sonkar, Sangeeta Singh, Satyendra Kumar Sonkar
-
The menopause transition as a critical window in obesity medicine: Visceral adiposity, sarcopenic obesity, and cardiometabolic risk
Publication date: September 2026 Source: Obesity Medicine, Volume 63 Author(s): Esther Ugo Alum, David Chukwu Obasi, Simon Uzor, Michael Obinna Eji, Emenike Benjamin Amadi, Akunna Perpetua Emeruwa, Ada Ak Akwari, Prince Nkemakolam...
-
Targeting neuropeptide Y receptors for obesity management: Mechanistic insights, pharmacological advances, and translational challenges
Publication date: September 2026 Source: Obesity Medicine, Volume 63 Author(s): Kalyani R. Thombre, Krishna R. Gupta, Milind J. Umekar
-
Gestational diabetes mellitus across the life course: Epigenetic programming, intergenerational cardiometabolic risk, and preventive strategies
Publication date: September 2026 Source: Obesity Medicine, Volume 63 Author(s): Somanaboina Padmakar
-
Feasibility of implementing systematic screening of disordered eating in routine diabetes care of youth with type 1 diabetes
Publication date: September 2026 Source: Obesity Medicine, Volume 63 Author(s): Caroline Bruun Abild, Lene Juel Solskov, Kurt Kristensen, Kristian Rokkedal, Loa Clausen, Sigrid Bjerge Gribsholt
-
Insulin resistance beyond adiposity: Recognizing non-obese phenotypes
Publication date: September 2026 Source: Obesity Medicine, Volume 63 Author(s): Raquel Cohen Shaooli
-
Obesity-driven high incidence of ovarian cancer: Molecular insights and therapeutic interventions targeting PI3K/AKT/mTOR, leptin-JAK/STAT, and NF-κB signaling pathways
Publication date: September 2026 Source: Obesity Medicine, Volume 63 Author(s): Amirul Hakim Mohd Azlan, Vetriselvan Subramaniyan, Lerh Chyi Ong, Gavin Stewart Dawe, Ram Narayanan Ravi
-
We are looking at the wrong place: Exercise beyond muscle mass preservation during incretin-based therapies
Publication date: September 2026 Source: Obesity Medicine, Volume 63 Author(s): Nathan Muci Aguiar, Guilherme Weiss Freccia, Marcos de Sá Rego Fortes, Marília Gabriela Zanier Gomes, Claudio Andre Barbosa de Lira
-
Corrigendum to “Elucidating the potential benefit of pump-delivered subcutaneous GLP-1R agonist: an exploratory study in the diet-induced obese mouse” [Obes. Med. 59, (2026), 100681]
Publication date: Available online 18 September 2026 Source: Obesity Medicine Author(s): Elaine Chiquette, Louise Thisted, Michael Feigh, Stephen Daly, James Besser, David G. Maggs
-
Are incretin-based therapies replacing metabolic bariatric surgery? A narrative review of surgical eligibility, perioperative integration, and patient decision-making
Publication date: November 2026 Source: Obesity Medicine, Volume 64 Author(s): M. Arbogast, M. Bayer, M. Biraima, W. Brunner, C. Rabl, P. Gerber, D. Gero
-
Cost-utility of semaglutide in the management of obesity or overweight: A systematic review
Publication date: November 2026 Source: Obesity Medicine, Volume 64 Author(s): Ronald Watema-Lord, Feng Xie, Chiranjeev Sanyal
-
Polyamine signaling in obesity: Microbiota-mediated spermidine and putrescine pathways in inflammation and metabolic homeostasis
Publication date: November 2026 Source: Obesity Medicine, Volume 64 Author(s): Saksham Saxena, Irshad Ahmed, Rajeev Kumar Jha, Naveen Kumar, Mansi Saxena, Susmita Chakrabarty, Ranjay Kumar Choudhary, Deepika Ahuja, M. Vinod Kumar,...
-
Clinical obesity, anthropometric characteristics and associated factors among adults with hypertension and/or diabetes attending an NCD clinic in a tertiary care hospital of Western Uttar Pradesh
Publication date: November 2026 Source: Obesity Medicine, Volume 64 Author(s): Suprakash Mandal, Kriti Singh, Deepshikha Verma, Anurag Srivastava, Rambha Pathak
-
Repurposing metabolic drugs: Anti-diabetic and anti-obesity agents with potential in cancer therapy
Publication date: November 2026 Source: Obesity Medicine, Volume 64 Author(s): Daniel Ejim Uti, Hailah M. Almohaimeed, Waheeb Sami Aggad, Josephine E. Egbung, Bassey Omeh Anthony, Ogar Rose Omari, Esther Ugo Alum
-
Digital twins in obesity: Emerging applications in prevention, prediction and personalised management
Publication date: November 2026 Source: Obesity Medicine, Volume 64 Author(s): Gloria C. Okoye, Joshua Opeyemi Adu, Damilola Akinsulire, Muyiwa Ademola Ogunbona, Osazuwa Ighodaro, David B. Olawade
-
Biosensors and bioimaging enable non-invasive real time glucose monitoring and early detection of complications in diabetes management
Publication date: November 2026 Source: Obesity Medicine, Volume 64 Author(s): Sarad Pawar Naik Bukke, Ananda Kumar Chettupalli, Chetan Banbarilal Sharma, Chandrashekar Thalluri, Bukke Pasunath Naik
-
Research trends in GLP-1 receptor agonist marketing, social media, and safety: A bibliometric analysis and focused narrative synthesis
Publication date: November 2026 Source: Obesity Medicine, Volume 64 Author(s): Derren DCH. Rampengan, Michael O. Hogipranata, Muhammad Iqhrammullah, Farrah Fahdhienie, Novie H. Rampengan, Maulana Empitu, Muhammad Habiburrahman
-
Prevalence of sarcopenic obesity in a Danish population of adults with obesity
Publication date: November 2026 Source: Obesity Medicine, Volume 64 Author(s): Tobias M. Windedal, Claus B. Juhl, Martin W. Kusk, Katrine Thelle, Josje Schoufour, Sören Möller, Bibi Gram
-
Factors associated with weight loss among adults currently receiving GLP-1-based therapy: A cross-sectional study
Publication date: November 2026 Source: Obesity Medicine, Volume 64 Author(s): Aysun Yuksel, Melike Aslihan Kara, Mine Ozkazanc-Akren, Hulya Yilmaz-Onal
-
Obesity in the GLP-1 Era: Clinical Characteristics and Prescribing Patterns in a Large Integrated Health System
Publication date: Available online 13 November 2026 Source: Obesity Medicine Author(s): Brian J. Wells, Kristin M. Lenoir, Michael Webster-Clark, Nicholas M. Pajewski, Amanda T. Pons-Junkins, Michelle M. Mielke